The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...

A recent study found that over a third of websites selling compounded diabetes and weight loss medications, such as Ozempic and Wegovy, falsely claim they are FDA-approved.

Two U.S. senators wrote a letter to the Food and Drug Administration on Friday expressing concerns about an upcoming Super ...

Shares of Denmark’s Novo Nordisk rose 3.5% to 613.30 kroner this morning, after the company reported better-than-expected net ...

"Excellent finish to the year with strong growth and high profitability" Fourth quarter and full year summary October - December Total revenues grew 48% (44% at CER1) to SEK 553 (375) million Sales ...

Two U.S. senators wrote a letter to the Food and Drug Administration on Friday expressing concerns about an upcoming Super ...

wrote a letter to the U.S. Food and Drug Administration ... advertisement," the senators wrote. "Further, for only three seconds during the minute-long commercial does the screen flash in small ...

The spot “is a clear violation” of the FDCA, “which requires that advertising for prescription drugs — including compounded ...

Perrysburg, Ohio, Feb. 05, 2025 (GLOBE NEWSWIRE) -- ...

Complete Response Letter issued ... NDA accepted for review Semaglutide 7.2mg (Novo Nordisk) Glucagon-like peptide-1 receptor agonist Treatment of obesity in adults. Phase 3 trial results ...